CPIG
BMRN icon

Chicago Partners Investment Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Chicago Partners Investment Group’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$713K Sell
12,109
-74
-0.6% -$4.05K 0.01% 812
2026
Q1 		$660K Buy
12,183
+290
+2% +$16.9K 0.01% 733
2025
Q4 		$669K Buy
11,893
+3,194
+37% +$174K 0.02% 613
2025
Q3 		$465K Buy
8,699
+2,555
+42% +$146K 0.01% 745
2025
Q2 		$367K Buy
+6,144
New +$362K 0.01% 741

Other funds holding BMRN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Chicago Partners Investment Group's BMRN Position: Q2 2026 in Review

Chicago Partners Investment Group reduced its BioMarin Pharmaceuticals (BMRN) stake by 0.61% in Q2 2026, selling an estimated $4.05K and leaving 12,109 shares worth $713K. The position accounts for 0.01% of the portfolio, ranked #812.

Chicago Partners Investment Group first reported a position in BMRN in Q2 2025 and has held it in 5 quarters since. 562 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Chicago Partners Investment Group held 12,109 shares of BioMarin Pharmaceuticals worth $713K as of Q2 2026.
  • Chicago Partners Investment Group sold 74 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $4.05K.
  • BioMarin Pharmaceuticals made up 0.01% of Chicago Partners Investment Group's portfolio in Q2 2026, its #812 holding.
  • Chicago Partners Investment Group first reported a position in BioMarin Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 562 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.